<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Medical devices pose unique challenges for economic evaluation and associated decision-making processes that differ from pharmaceuticals </plain></SENT>
<SENT sid="1" pm="."><plain>We highlight and discuss these challenges in the context of cardiac device therapy, based on a systematic review of relevant economic evaluations </plain></SENT>
<SENT sid="2" pm="."><plain>Key challenges include practical difficulties in conducting randomized clinical trials, allowing for a 'learning curve' and user characteristics, accounting for the wider organizational impacts of introducing new devices, and allowing for variations in product characteristics and prices over time </plain></SENT>
</text></document>